NCT05371145View on ClinicalTrials.gov

Carnosine for Peripheral Arterial Disease Patients

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2024

Conditions
Peripheral Arterial Disease
Interventions
BIOLOGICAL

Carnosine

Determine whether carnosine supplementation (2 g/day) for 3 months in peripheral arterial disease patients improves 6MWT ability.

Trial Locations (1)

40202

RECRUITING

University of Louisville, Louisville

All Listed Sponsors
lead

Shahid Baba

OTHER